Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: Lung cancer is a devastating disease, with non-small cell lung cancer (NSCLC) being the most common subtype. With the development of novel targeted therapeutics, survival times have continuously improved over the past two decades. In a subset of NSCLC, gene rearrangements of the anap...

Descripción completa

Detalles Bibliográficos
Autores principales: Smolle, Elisabeth, Taucher, Valentin, Lindenmann, Joerg, Jost, Philipp J., Pichler, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915291/
https://www.ncbi.nlm.nih.gov/pubmed/33572278
http://dx.doi.org/10.3390/cancers13040699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915291/
https://www.ncbi.nlm.nih.gov/pubmed/33572278
http://dx.doi.org/10.3390/cancers13040699

Ejemplares similares